| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.032 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |